老年肺部感染致中性粒细胞靶向迁移受损,辛伐他汀可改善
研究评估年轻与老年人在健康及下呼吸道感染、社区获得性肺炎和脓毒症相关肺炎时血中性粒细胞的迁移准确性,并观察辛伐他汀的影响。体外实验显示老年中性粒细胞迁移准确性随感染严重程度加重而恶化,6周未恢复;辛伐他汀在健康老年和轻中度感染中可挽救迁移,但在严重脓毒症中无效。健康老年人双盲随机临床试验证实高剂量(80 mg)辛伐他汀改善中性粒细胞迁移准确性且不损害其他功能。
要点
- 老年肺部感染后中性粒细胞迁移准确性持续受损,6周未恢复。
- 辛伐他汀在健康老年和轻中度感染中改善中性粒细胞迁移,严重脓毒症无效。
- 健康老年人双盲随机试验中80 mg辛伐他汀改善迁移且不损害其他中性粒细胞功能。
核心结论
- 老年人感染与持续性中性粒细胞迁移受损相关,可能促成不良结局。
- 辛伐他汀在健康体内和轻中度感染体外改善中性粒细胞迁移,但在严重脓毒症中无效。
研究设计与样本
- 体外评估年轻(<35岁)与老年(>60岁)患者在健康、下呼吸道感染、社区获得性肺炎及脓毒症相关肺炎时血中性粒细胞迁移准确性,并检测辛伐他汀影响。
- 体外结果在健康老年人双盲随机临床试验中验证,并评估细胞黏附标志物。
主要发现
- 老年中性粒细胞迁移准确性随感染性肺部损伤严重程度增加而恶化,6周未恢复。
- 辛伐他汀在老年和轻中度感染中挽救中性粒细胞迁移,高剂量用于老年人,但严重脓毒症中无效。
- 健康老年人双盲随机试验中高剂量(80 mg)辛伐他汀改善中性粒细胞迁移准确性且不阻碍其他中性粒细胞功能。
- 辛伐他汀改变表面黏附分子表达和活性,促进老年人准确迁移。
临床怎么用
- 支持辛伐他汀作为肺部感染早期干预的潜在用途,尤其在轻中度感染阶段。
- 严重脓毒症时辛伐他汀对中性粒细胞迁移的改善作用有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Dysregulated neutrophil functions with age and sepsis are described. Statins are associated with improved infection survival in some observational studies, but trials in critically ill patients have not shown benefit. Statins also alter neutrophil responses in vitro. OBJECTIVES: To assess neutrophil migratory accuracy with age during respiratory infections and determine if and how a statin intervention could alter these blunted responses. METHODS: The migratory accuracy of blood neutrophils from young (aged <35 yr) and old (aged >60 yr) patients in health and during a lower respiratory tract infection, community-acquired pneumonia, and pneumonia associated with sepsis was assessed with and without simvastatin. In vitro results were confirmed in a double-blind randomized clinical trial in healthy elders. Cell adhesion markers were assessed. MEASUREMENTS AND MAIN RESULTS: In vitro neutrophil migratory accuracy in the elderly deteriorated as the severity of the infectious pulmonary insult increased, without recovery at 6 weeks. Simvastatin rescued neutrophil migration with age and during mild to moderate infection, at high dose in older adults, but not during more severe sepsis. Confirming in vitro results, high-dose (80-mg) simvastatin improved neutrophil migratory accuracy without impeding other neutrophil functions in a double-blind randomized clinical trial in healthy elders. Simvastatin modified surface adhesion molecule expression and activity, facilitating accurate migration in the elderly. CONCLUSIONS: Infections in older adults are associated with prolonged, impaired neutrophil migration, potentially contributing to poor outcomes. Statins improve neutrophil migration in vivo in health and in vitro in milder infective events, but not in severe sepsis, supporting their potential utility as an early intervention during pulmonary infections. Clinical trial registered with www.clinicaltrialsregister.eu (2011-002082-38).
引用
- Sapey E, Patel JM, Greenwood HL, et al. Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin. Am J Respir Crit Care Med. 2017. PMID: 28657793. doi:10.1164/rccm.201704-0814OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。